| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0068 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.061 | 1 |